{"id":22641,"date":"2018-01-26T11:25:04","date_gmt":"2018-01-26T11:25:04","guid":{"rendered":"https:\/\/corporate.webfactory.ferring.tech\/?p=22641"},"modified":"2023-03-31T08:31:51","modified_gmt":"2023-03-31T07:31:51","slug":"ferring-announces-recipients-of-innovation-grants-program-2017-2018","status":"publish","type":"post","link":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/","title":{"rendered":"Ferring Announces Recipients of Innovation Grants Program 2017-2018"},"content":{"rendered":"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h2 style=\"color: #0088ce\">Ferring Announces Recipients of Innovation Grants Program 2017-2018<\/h2>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">Saint-Prex, Switzerland \u2013 26 January, 2018 \u2013<\/h3>\n<p>Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in San Diego. This global program supports research in the fields of reproductive medicine and women\u2019s health, urology, gastroenterology, hepatology, and endocrinology.<\/p>\n<p><em>\u201cThe quality of applications received in response to the 2017-2018 Ferring Innovation Grants call for proposals was outstanding.\u00a0 We have funded programs that we believe represent the leading edge of research in their therapeutic fields, and very much look forward to seeing the outcome of the innovative projects proposed by this year\u2019s grant awardees,\u201d<\/em>\u00a0said Keith James, President Ferring Research Institute, Senior Vice President Research and Development.<\/p>\n<p>Now in its fifth year, the Innovation Grants Program received 300 submissions. Each submission was reviewed for its scientific merit, and a short list of finalists were invited to submit more detailed applications for consideration. \u00a0A total of 13 projects were chosen to receive grant funding from Ferring this year. In addition to the United States, projects have been funded in Canada, the United Kingdom, Australia, and Portugal. This year\u2019s recipients, together with the grant titles, are:<sup>\u00a0<\/sup><\/p>\n<ul>\n<li><strong>St\u00e9phane Bolduc<\/strong>\u00a0&#8211; CHU de Qu\u00e9bec &#8211; Universit\u00e9 Laval Research Center<br \/>\n<em>Identify protein(s) secreted by urothelial cell carcinoma (UCC) involved in modification of tumor-associated stroma by activation of Cancer-Associated Fibroblasts (CAF).<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Marcello Costa<\/strong>\u00a0&#8211; Flinders University<br \/>\n<em>Enteric neuropeptides modulation of colonic motility in health and disease<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Warren Foster\u00a0<\/strong>&#8211; McMaster University<br \/>\n<em>Evaluation of a novel therapeutic intervention for the management of endometriosis in a mouse model<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Andrew Horne<\/strong>\u00a0&#8211; University of Edinburgh<br \/>\n<em>Targeting TGF\u03b2-1 with an extracellular peptide inhibitor to treat women with peritoneal endometriosis<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Joseph Hurt<\/strong>\u00a0&#8211; University of Colorado School of Medicine<br \/>\n<em>Adiponectin receptor regulation of myometrial contractility suggests novel therapeutic targets to augment uterine quiescence and prevent preterm birth<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Ursula Kaiser<\/strong>\u00a0&#8211; Brigham and Women&#8217;s Hospital, Harvard Medical School<br \/>\n<em>Differential modulation of LH and FSH by GnRH analogs for improved treatment of reproductive disorders<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Sarah Marshall<\/strong>\u00a0&#8211; Monash University<br \/>\n<em>Exploring novel therapies for preeclampsia: the role of soluble prorenin receptor on vasculature function<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Kathryn Meier<\/strong>\u00a0&#8211; Washington State University<br \/>\n<em>FSH receptor as a therapeutic target in prostate cancer<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Victor Navarro<\/strong>\u00a0&#8211; Brigham and Women&#8217;s Hospital, Harvard Medical School<br \/>\n<em>Targeting the Kappa Opioid Receptor to Regulate LH Pulses in PCOS Patients<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Willis Samson\u00a0<\/strong>&#8211; Saint Louis University School of Medicine<br \/>\n<em>A Novel Ligand (Adropin) \u2013 Receptor (GPR19) Handshake: Implications for the Control of Growth Hormone Secretion<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>John Taylor<\/strong>\u00a0&#8211; Kansas University Medical Center<br \/>\n<em>The Role of d-Dopachrome Tautomerase in Bladder Cancer Tumorigenesis<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Suraj Unniappan<\/strong>\u00a0&#8211; University of Saskatchewan<\/li>\n<li><em>Nesfatin-1 and Nesfatin-1 Like Peptide Regulation of Growth and Stress Hormones: Novel Targets for Endocrine Diseases<\/em><\/li>\n<\/ul>\n<ul>\n<li><strong>Henrique Veiga-Fernandes<\/strong>\u00a0&#8211; Champalimaud Foundation<br \/>\n<em>Activation of type 3 Innate Lymphoid Cells and innate IL-22 secretion via RET signaling for Inflammatory Bowel Disease treatment<\/em><\/li>\n<\/ul>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">About Ferring Pharmaceuticals<\/h3>\n<p>Ferring Pharmaceuticals is a research-driven, speciality biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women\u2019s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company\u2019s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth. Founded in 1950, Ferring now employs approximately 7,000 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.<\/p>\n<p>Learn more at\u00a0<a href=\"https:\/\/www.ferring.com\/\">www.ferring.com<\/a>\u00a0and\u00a0<a href=\"https:\/\/twitter.com\/ferring\">@Ferring<\/a>, or connect with us on <a href=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\">Facebook<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.linkedin.com\/company\/ferring-pharmaceuticals\/\">LinkedIn<\/a>.<\/p>\n<h3 style=\"color: #0088ce\">About Ferring Research Institute Inc<\/h3>\n<p>Located in San Diego, California Ferring Research Institute Inc. (FRI) is a global therapeutics research center for Ferring Pharmaceuticals.\u00a0 FRI is committed to delivering a pipeline of innovative therapies which improve the lives of patients in the areas of reproductive medicine and women\u2019s health, urology, gastroenterology and hepatology.<\/p>\n<p>For more detailed information please visit <a href=\"https:\/\/www.ferringusa.com\/\">www.ferring-research.com<\/a>.<\/p>\n[\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;]\n<h3 style=\"color: #0088ce\">For more information, please contact<\/h3>\n<p><strong>Lindsey Rodger<br \/>\n<\/strong><em>Senior Manager, Corporate Communications<br \/>\n<\/em>+41 58 451 40 23 (direct)<br \/>\n+41 79 191 0486 (mobile)<br \/>\n<span class=\"antispam\"><a href=\"mailto:lindsey.rodger@ferring.com\">lindsey.rodger@ferring.com<\/a><\/span><\/p>\n<p><strong>Bhavin Vaid<br \/>\n<\/strong><em>Head of Corporate Communications<br \/>\n<\/em>+41 58 301 09 52 (direct)<br \/>\n+41 79 191 06 32 (mobile)<br \/>\n<span class=\"antispam\"><a href=\"mailto:bhavin.vaid@ferring.com\">bhavin.vaid@ferring.com<\/a><\/span><\/p>\n[\/spb_boxed_content] [spb_row element_name=&#8221;Row&#8221; wrap_type=&#8221;content-width&#8221; parallax_image_height=&#8221;content-height&#8221; parallax_image_movement=&#8221;fixed&#8221; parallax_image_speed=&#8221;0.5&#8243; bg_video_loop=&#8221;yes&#8221; parallax_video_height=&#8221;window-height&#8221; parallax_video_overlay=&#8221;none&#8221; row_overlay_opacity=&#8221;0&#8243; row_col_pos=&#8221;default&#8221; minimize_row=&#8221;no&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_button button_text=&#8221;READ MORE PRESS RELEASES&#8221; button_size=&#8221;standard&#8221; button_colour=&#8221;accent&#8221; button_type=&#8221;standard&#8221; rounded=&#8221;no&#8221; button_dropshadow=&#8221;no&#8221; button_link=&#8221;\/media\/press-releases\/&#8221; button_target=&#8221;_self&#8221; align=&#8221;center&#8221; animation=&#8221;none&#8221; animation_delay=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [\/spb_row]\n","protected":false},"excerpt":{"rendered":"<p>[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring Announces Recipients of Innovation Grants Program 2017-2018 [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 26 January, 2018 \u2013 Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in [&hellip;]<\/p>\n","protected":false},"author":2410,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[243],"tags":[],"class_list":["post-22641","post","type-post","status-publish","format-standard","hentry","category-press-release-2018"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.3 (Yoast SEO v23.3) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ferring Announces Recipients of Innovation Grants Program 2017-2018 - Ferring Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ferring Announces Recipients of Innovation Grants Program 2017-2018\" \/>\n<meta property=\"og:description\" content=\"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring Announces Recipients of Innovation Grants Program 2017-2018 [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 26 January, 2018 \u2013 Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\" \/>\n<meta property=\"og:site_name\" content=\"Ferring Global\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-01-26T11:25:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-31T07:31:51+00:00\" \/>\n<meta name=\"author\" content=\"pulse\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ferring\" \/>\n<meta name=\"twitter:site\" content=\"@ferring\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"pulse\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\"},\"author\":{\"name\":\"pulse\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\"},\"headline\":\"Ferring Announces Recipients of Innovation Grants Program 2017-2018\",\"datePublished\":\"2018-01-26T11:25:04+00:00\",\"dateModified\":\"2023-03-31T07:31:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\"},\"wordCount\":942,\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"articleSection\":[\"PRESS RELEASE 2018\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\",\"url\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\",\"name\":\"Ferring Announces Recipients of Innovation Grants Program 2017-2018 - Ferring Global\",\"isPartOf\":{\"@id\":\"https:\/\/www.ferring.com\/#website\"},\"datePublished\":\"2018-01-26T11:25:04+00:00\",\"dateModified\":\"2023-03-31T07:31:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ferring.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ferring Announces Recipients of Innovation Grants Program 2017-2018\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ferring.com\/#website\",\"url\":\"https:\/\/www.ferring.com\/\",\"name\":\"Ferring Pharmaceuticals\",\"description\":\"Helping people live better lives\",\"publisher\":{\"@id\":\"https:\/\/www.ferring.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ferring.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ferring.com\/#organization\",\"name\":\"Ferring\",\"url\":\"https:\/\/www.ferring.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"contentUrl\":\"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png\",\"width\":236,\"height\":154,\"caption\":\"Ferring\"},\"image\":{\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/ferringpharmaceuticals\/\",\"https:\/\/x.com\/ferring\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d\",\"name\":\"pulse\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ferring.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g\",\"caption\":\"pulse\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ferring Announces Recipients of Innovation Grants Program 2017-2018 - Ferring Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/","og_locale":"en_US","og_type":"article","og_title":"Ferring Announces Recipients of Innovation Grants Program 2017-2018","og_description":"[spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Ferring Announces Recipients of Innovation Grants Program 2017-2018 [\/spb_boxed_content] [spb_blank_spacer height=&#8221;30px&#8221; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] [spb_boxed_content type=&#8221;coloured&#8221; box_link_target=&#8221;_self&#8221; padding_vertical=&#8221;0&#8243; padding_horizontal=&#8221;0&#8243; width=&#8221;1\/1&#8243; el_position=&#8221;first last&#8221;] Saint-Prex, Switzerland \u2013 26 January, 2018 \u2013 Ferring Pharmaceuticals today announced the recipients of the 2017-2018 Innovation Grants Program, an annual initiative of the Ferring Research Institute (FRI) based in [&hellip;]","og_url":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/","og_site_name":"Ferring Global","article_publisher":"https:\/\/www.facebook.com\/ferringpharmaceuticals\/","article_published_time":"2018-01-26T11:25:04+00:00","article_modified_time":"2023-03-31T07:31:51+00:00","author":"pulse","twitter_card":"summary_large_image","twitter_creator":"@ferring","twitter_site":"@ferring","twitter_misc":{"Written by":"pulse","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#article","isPartOf":{"@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/"},"author":{"name":"pulse","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d"},"headline":"Ferring Announces Recipients of Innovation Grants Program 2017-2018","datePublished":"2018-01-26T11:25:04+00:00","dateModified":"2023-03-31T07:31:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/"},"wordCount":942,"publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"articleSection":["PRESS RELEASE 2018"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/","url":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/","name":"Ferring Announces Recipients of Innovation Grants Program 2017-2018 - Ferring Global","isPartOf":{"@id":"https:\/\/www.ferring.com\/#website"},"datePublished":"2018-01-26T11:25:04+00:00","dateModified":"2023-03-31T07:31:51+00:00","breadcrumb":{"@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ferring.com\/ferring-announces-recipients-of-innovation-grants-program-2017-2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ferring.com\/"},{"@type":"ListItem","position":2,"name":"Ferring Announces Recipients of Innovation Grants Program 2017-2018"}]},{"@type":"WebSite","@id":"https:\/\/www.ferring.com\/#website","url":"https:\/\/www.ferring.com\/","name":"Ferring Pharmaceuticals","description":"Helping people live better lives","publisher":{"@id":"https:\/\/www.ferring.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ferring.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ferring.com\/#organization","name":"Ferring","url":"https:\/\/www.ferring.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/","url":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","contentUrl":"https:\/\/d2gohj824v350l.cloudfront.net\/wp-content\/uploads\/sites\/16\/2024\/01\/12104451\/Ferring-logo-7.png","width":236,"height":154,"caption":"Ferring"},"image":{"@id":"https:\/\/www.ferring.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ferringpharmaceuticals\/","https:\/\/x.com\/ferring"]},{"@type":"Person","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/d1f92e22aded72904a8e0a8cdc7bcd3d","name":"pulse","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ferring.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc40dcfa5383773cc16d79b62c8436d?s=96&d=mm&r=g","caption":"pulse"}}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22641"}],"collection":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/users\/2410"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/comments?post=22641"}],"version-history":[{"count":1,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22641\/revisions"}],"predecessor-version":[{"id":28958,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/posts\/22641\/revisions\/28958"}],"wp:attachment":[{"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/media?parent=22641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/categories?post=22641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ferring.com\/wp-json\/wp\/v2\/tags?post=22641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}